https://www.selleckchem.com/pr....oducts/abtl-0812.htm
clinical trials investigating cognition, providing a means for monitoring changes in myelination and its association with symptom worsening or improvement. This study used MWI to demonstrate that otherwise normal-appearing brain tissue is diffusely damaged in MS, and the findings suggest that myelin water measures are associated with cognitive performance. MWI offers an in vivo biomarker feasible for use in clinical trials investigating cognition, providing a means for monitoring changes in myelination and its association with symptom
Like
Comment
Share
